2.7155
Schlusskurs vom Vortag:
$2.71
Offen:
$2.8
24-Stunden-Volumen:
3,638
Relative Volume:
0.23
Marktkapitalisierung:
$17.98M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.83M
KGV:
-6.0344
EPS:
-0.45
Netto-Cashflow:
$-24.55M
1W Leistung:
-23.68%
1M Leistung:
-47.07%
6M Leistung:
-43.53%
1J Leistung:
-63.71%
Movano Inc Stock (MOVE) Company Profile
Firmenname
Movano Inc
Sektor
Branche
Telefon
408-393-1209
Adresse
6800 KOLL CENTER PARKWAY, PLEASANTON
Vergleichen Sie MOVE mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
MOVE
Movano Inc
|
2.70 | 17.98M | 0 | -26.83M | -24.55M | -0.45 |
![]()
ABT
Abbott Laboratories
|
125.98 | 221.85B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
97.00 | 142.24B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
370.00 | 140.07B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
93.04 | 118.98B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
68.68 | 40.31B | 5.72B | 4.17B | 259.90M | 6.97 |
Movano Inc Aktie (MOVE) Neueste Nachrichten
Movano's Evie Ring Adds New Personalization and Trend Tracking to Support Women's Wellness Journey - PR Newswire
Movano stock hits 52-week low at $2.75 amid market challenges - Investing.com
(MOVE) Technical Data - Stock Traders Daily
Movano Starts Cuffless Blood Pressure Wearable Device Clinical Study -February 04, 2025 at 10:53 am EST - Marketscreener.com
Movano Health Commences Clinical Study with New Cuffless Blood Pressure Device - WV News
Movano Health Launches EvieAI Virtual Wellness Assistant - Quantisnow
Movano Appoints Shaheen Wirk to Board of Directors - TipRanks
Movano Health expands board with healthcare investment expert By Investing.com - Investing.com Canada
Movano Health Welcomes Dr. Shaheen Wirk to its Board of Directors - PR Newswire
Movano Health Opens Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split - Longview News-Journal
Movano Health Provides Update on FDA Review of EvieMED Ring - Kilgore News Herald
Movano (NASDAQ:MOVE) versus Pixie Dust Technologies (NASDAQ:PXDT) Financial Analysis - Defense World
Movano receives FDA nod for smart ring’s pulse oximeter feature - MedTech Dive
Movano Health gets FDA clearance for its EvieMED Ring - Gadgets & Wearables
Movano rings up FDA pulse ox clearance for Eviemed - BioWorld Online
Movano Health's EvieMED Ring Secures FDA Clearance, Targets $40B Healthcare Market - StockTitan
Movano Health Receives FDA Clearance for EvieMED Ring - PR Newswire
Movano Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Movano stock hits 52-week low at $3.01 amid market challenges - Investing.com
Movano Inc. (NASDAQ:MOVE) Q3 2024 Earnings Call Transcript - MSN
Movano Focuses on EvieMED Ring FDA Review and New B2B Partnerships - Sleep Review
Movano Health Updates on Financial and Strategic Progress - TipRanks
Movano Health Narrows Losses, Advances Evie Ring Sales and FDA Clearance Push | MOVE Stock News - StockTitan
Movano Health Reports Q3 2024 Financial Results and Provides Business Update - PR Newswire
Head to Head Survey: Movano (NASDAQ:MOVE) versus Integer (NYSE:ITGR) - Defense World
MOVEMovano Inc. Latest Stock News & Market Updates - StockTitan
Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device - PR Newswire
Movano Health to Report Third Quarter 2024 Financial Results on Thursday November 14, 2024 - StockTitan
Movano seeks FDA clearance for EvieMED health ring By Investing.com - Investing.com Canada
Movano Health investigates stock manipulation post-split By Investing.com - Investing.com Canada
Movano sumitts complete EvieMED Ring response package to the FDA - TipRanks
Movano provides update on investigation regarding apparent manipulation - TipRanks
Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split - PR Newswire
Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED - PR Newswire
Movano (MOVE) Stock Rallies After Hours Amid Trading Manipulation Concerns - Stocks Telegraph
Movano opens investigation to expose apparent stock manipulation - TipRanks
Movano Health probes stock manipulation after reverse split By Investing.com - Investing.com Australia
Movano stock hits 52-week low at $3.53 amid market challenges By Investing.com - Investing.com South Africa
Movano stock hits 52-week low at $3.53 amid market challenges - Investing.com
Evie Ring Announces Brand Partnership with Lifestyle Content Creator Heidi D'Amelio - PR Newswire
Movano Health announces 1-for-15 reverse stock split - MSN
Movano Implements Reverse Stock Split to Maintain Nasdaq Listing - TipRanks
Movano Health Announces Reverse Stock Split - PR Newswire
Movano Health nears final FDA review phase for EvieMED ring By Investing.com - Investing.com Canada
Movano Health Plans Response Submission to FDA Next Week as Part of EvieMED Final Review Phase - PR Newswire
Movano Health nears FDA clearance for EvieMED Ring By Investing.com - Investing.com Canada
Finanzdaten der Movano Inc-Aktie (MOVE)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):